From the Editor
From the Editor
Self-deception : A double-edged trait
Psychiatric disorders are extremes of self-deception gone awry across complex neural pathways.
From the Editor
Your vote, please: What’s ailing psychiatry?
Rank 17 challenges to psychiatry on a scale from 10 (highest importance) to 1 (lowest importance)
From the Editor
Is schizophrenia recovery a ‘myth’?
I have obtained dramatic functional recovery after giving injectable second-generation antipsychotics continuously for 2 years or more
From the Editor
Breakthrough drugs and sponsorless CME: How the FDA can help
Could extending pharmaceutical companies’ patents give us innovative treatments and independent CME funding?
From the Editor
Bring back the asylums?
The tragic consequences of deinstitutionalization.
From the Editor
Pregnant and mentally ill: A labor-intensive clinical challenge
FDA rankings of drugs’ teratogenic potential are guided by the lowest tier of evidence-based medicine.
From the Editor
What if …
A drug company’s New Year’s resolutions.
From the Editor
Is schizophrenia a psychotic disorder?
Psychosis may be a secondary symptom that emerges as a consequence of cognitive impairment.
From the Editor
Innovative polypharmacy: When dopamine blockade is not enough
‘Futuristic’ adjuncts to antipsychotics could better address persistent positive and negative symptoms and impaired cognition.
From the Editor
Remember the hippocampus!: You can protect the brain’s ‘regeneration center’
Stress management, physical and mental exercise, and some medications can keep the hippocampus active, allow neurogenesis.
From the Editor
How should dementia with psychosis be treated?
The mortality risk of SGAs vs FGAs is what really matters to clinicians who prefer SGAs but are intimidated by the black-box warning.